HK1206977A1 - Aromatic-cationic peptides and uses of same - Google Patents
Aromatic-cationic peptides and uses of sameInfo
- Publication number
- HK1206977A1 HK1206977A1 HK15107556.4A HK15107556A HK1206977A1 HK 1206977 A1 HK1206977 A1 HK 1206977A1 HK 15107556 A HK15107556 A HK 15107556A HK 1206977 A1 HK1206977 A1 HK 1206977A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- aromatic
- same
- cationic peptides
- peptides
- cationic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261623348P | 2012-04-12 | 2012-04-12 | |
PCT/US2013/036222 WO2013155334A1 (en) | 2012-04-12 | 2013-04-11 | Aromatic-cationic peptides and uses of same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1206977A1 true HK1206977A1 (en) | 2016-01-22 |
Family
ID=49328169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107556.4A HK1206977A1 (en) | 2012-04-12 | 2015-08-06 | Aromatic-cationic peptides and uses of same |
Country Status (8)
Country | Link |
---|---|
US (3) | US20150119552A1 (ja) |
EP (1) | EP2836227A4 (ja) |
JP (2) | JP2015514134A (ja) |
CN (2) | CN105753939A (ja) |
AU (2) | AU2013245805A1 (ja) |
CA (1) | CA2870200A1 (ja) |
HK (1) | HK1206977A1 (ja) |
WO (1) | WO2013155334A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9988422B2 (en) | 2011-09-29 | 2018-06-05 | Stealth Biotherapeutics Corp | Aromatic-cationic peptides and methods for using same |
US20180042983A1 (en) * | 2015-02-13 | 2018-02-15 | Stealth Peptides International, Inc. | Therapeutic compositions including mitochondrial fission inhibitor peptides, variants thereof, and methods of using the same |
JP2019523260A (ja) | 2016-04-11 | 2019-08-22 | カーノット, エルエルシー | キラルペプチド |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804558A (en) * | 1993-07-20 | 1998-09-08 | University Of California | Protegrins |
US20020173475A1 (en) * | 2001-04-16 | 2002-11-21 | Asim Dasgupta | Methods to inhibit viral replication |
EP3381515B1 (en) * | 2003-05-01 | 2020-07-08 | Cornell Research Foundation, Inc. | Carrier complexes for delivering molecules to cells |
DK2252627T3 (en) * | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
US20120329730A1 (en) * | 2010-01-25 | 2012-12-27 | Institut De Recherches Cliniques De Montreal | Aromatic-cationic peptides and uses of same |
EP3130599A1 (en) * | 2010-05-03 | 2017-02-15 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
CN106039282A (zh) * | 2011-10-17 | 2016-10-26 | 康奈尔大学 | 芳香族阳离子肽及其用途 |
AU2012347931A1 (en) * | 2011-12-09 | 2014-07-03 | Stealth Peptides International, Inc. | Aromatic-cationic peptides and uses of same |
JP2015509504A (ja) * | 2012-02-23 | 2015-03-30 | コーネル ユニヴァーシティー | 芳香族陽イオン性ペプチドおよびその使用 |
-
2013
- 2013-04-11 CN CN201610124377.7A patent/CN105753939A/zh active Pending
- 2013-04-11 US US14/391,665 patent/US20150119552A1/en not_active Abandoned
- 2013-04-11 CN CN201380028086.2A patent/CN104334181A/zh active Pending
- 2013-04-11 CA CA2870200A patent/CA2870200A1/en not_active Abandoned
- 2013-04-11 JP JP2015505917A patent/JP2015514134A/ja active Pending
- 2013-04-11 AU AU2013245805A patent/AU2013245805A1/en not_active Abandoned
- 2013-04-11 EP EP13775320.8A patent/EP2836227A4/en not_active Withdrawn
- 2013-04-11 WO PCT/US2013/036222 patent/WO2013155334A1/en active Application Filing
-
2015
- 2015-08-06 US US14/819,971 patent/US20160194356A1/en not_active Abandoned
- 2015-08-06 HK HK15107556.4A patent/HK1206977A1/xx unknown
-
2016
- 2016-10-05 US US15/285,914 patent/US20170218016A1/en not_active Abandoned
-
2017
- 2017-07-28 JP JP2017146045A patent/JP2017203036A/ja active Pending
- 2017-11-20 AU AU2017261638A patent/AU2017261638A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN104334181A (zh) | 2015-02-04 |
WO2013155334A1 (en) | 2013-10-17 |
US20170218016A1 (en) | 2017-08-03 |
CN105753939A (zh) | 2016-07-13 |
AU2013245805A1 (en) | 2014-10-30 |
EP2836227A4 (en) | 2015-12-02 |
CA2870200A1 (en) | 2013-10-17 |
US20160194356A1 (en) | 2016-07-07 |
US20150119552A1 (en) | 2015-04-30 |
EP2836227A1 (en) | 2015-02-18 |
JP2017203036A (ja) | 2017-11-16 |
AU2017261638A1 (en) | 2017-12-07 |
JP2015514134A (ja) | 2015-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223550A1 (zh) | 芳香族陽離子肽及其用途 | |
HK1244540A1 (zh) | 芳香族陽離子肽及其用途 | |
HK1197028A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1208686A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1253343A1 (zh) | 新穎縮肽及其用途 | |
HK1201443A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1204772A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1213269A1 (zh) | 脯氨酸鎖定訂肽及其用途 | |
HK1199892A1 (en) | Modified mini-hepcidin peptides and methods of using thereof | |
EP2870170A4 (en) | NOVEL PEPTIDES AND THEIR USE | |
EP2566880A4 (en) | AROMATIC-CATIONIC PEPTIDES AND USES THEREOF | |
IL230918A0 (en) | Modified proteins and peptides | |
EP2740741A4 (en) | PEPTIDE OBTAINED FROM THE WNT FAMILY AND USES THEREOF | |
SG11201500111VA (en) | Peptides and uses thereof | |
HK1203161A1 (en) | Peptides and methods of using same | |
EP2782589A4 (en) | ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE | |
SG10201701828WA (en) | Peptides and their uses | |
EP2738255A4 (en) | PEPTIDE FROM ERAP1 AND ITS USE | |
EP2593595A4 (en) | NOVEL PEPTIDES AND USES THEREOF | |
EP2793921A4 (en) | PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF | |
IL237135B (en) | Peptide library and their uses | |
PL2627668T3 (pl) | Peptydy i ich zastosowanie | |
EP2825548A4 (en) | MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF | |
PL3346273T3 (pl) | Nowe, pochodzące od d3 d-enancjomeryczne peptydy i ich zastosowanie | |
EP2740740A4 (en) | PEPTIDE DERIVED FROM A LIGAND EDAR AND USES THEREOF |